Finally, the identification of a fusion between MYBL1 and NFIB genes in tumors without MYB aberration [6, 7], demonstrates that the pathogenesis of ACC may be driven by genetic alterations in another member of the same transcription factor (TF) gene family. This evidence concerns the gene TF and adrenal cortex carcinoma.